Table 3: Survey results for patients with diabetes, caregivers, and specialists.
|
T1D PWD N = 100 |
T1D CG N = 100 |
T2D MTI N = 100 |
T2D BI N = 100 |
Specialists N = 200 |
% who agree Gvoke HypoPen is easy-to-use |
95 |
94 |
94 |
93 |
95 |
% who agree Gvoke HypoPen gives confidence in others' ability to administer treatment during severe hypoglycemia episode |
94 |
98 |
88 |
92 |
94 |
% who agree Gvoke HypoPen gives confidence in ability to self-administer treatment during severe hypoglycemia episode |
86 |
91 |
93 |
93 |
90 |
% who agree Gvoke PFS is easy-to-use |
90 |
94 |
90 |
87 |
91 |
% who agree Gvoke PFS gives confidence in others' ability to administer treatment during severe hypoglycemia episode |
87 |
95 |
88 |
91 |
90 |
% who agree Gvoke PFS gives confidence in ability to self-administer treatment during severe hypoglycemia episode |
91 |
90 |
90 |
86 |
77 |
% who want HCP to proactively discuss new treatment options for managing severe hypoglycemia episodes |
89 |
98 |
85 |
84 |
72 |